PureTech Health PLC (PRTC) ニュース

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PureTech Health plc – Half-Year Report

Strong progress across PureTech’s portfolio, with significant near-term catalysts Robust shareholder returns enabled by Founded Entity1...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PureTech Appoints Michele Holcomb, PhD, to Board of Directors

Strategic healthcare leader brings more than 30 years of global experience to PureTech’s Board following...

PureTech Health: Notice of Half-Yearly Results

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to announce its half-yearly results for the six months ended...

PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors

Prominent pharmaceutical leader from AstraZeneca, Abbott, GlaxoSmithKline and Eli Lilly, brings extensive regulatory affairs and clinical...

PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial

Appointments support ongoing Phase 2 COLLECTiVE202 trial of VE202, pivotal Phase 3 RESTORATiVE303 trial of VE303 and planning for commercial...

PureTech Health: Completion of Tender Offer & Total Voting Rights

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the...

PureTech Health: Results of the Tender Offer

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the...

PureTech Announces Change of Board Role

Raju Kucherlapati, PhD, distinguished Professor of Medicine at Harvard Medical School, has transitioned to the...

PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team

Antony Loebel, M.D., CNS drug development expert and former CEO and CMO at Sunovion Pharmaceuticals, appointed as Seaport’s Chief Medical Officer...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PureTech Health: Results of Annual General Meeting

The Annual General Meeting of PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech Health” or the “Company”) was held at 11 a.m. EDT/4 p.m...

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]